Novartis earnings narrowly miss expectations, shares down 2%

Swiss drugmaker Novartis reported slightly weaker-than-expected quarterly earnings on Wednesday, prompting shares to fall more than 2 percent shortly after the opening bell.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.